126 related articles for article (PubMed ID: 7038462)
1. Induction of petite formation in Saccharomyces cerevisiae by experimental antitumour agents. Structure--activity relationships for 9-anilinoacridines.
Ferguson LR; Baguley BC
Mutat Res; 1981 Dec; 90(4):411-23. PubMed ID: 7038462
[TBL] [Abstract][Full Text] [Related]
2. Inverse correlation between bacterial frameshift mutagenicity and yeast mitochondrial effects of antitumour anilinoacridines.
Baguley BC; Ferguson LR
Chem Biol Interact; 1985 Dec; 56(2-3):145-55. PubMed ID: 3907865
[TBL] [Abstract][Full Text] [Related]
3. Apparent changes in structure-activity relationships for antimitochondrial effects of 9-anilinoacridines according to Saccharomyces cerevisiae strain and methodology.
Ferguson LR
Mutat Res; 1984 Jun; 136(3):223-31. PubMed ID: 6377059
[TBL] [Abstract][Full Text] [Related]
4. Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systems.
Baguley BC; Nash R
Eur J Cancer (1965); 1981 Jun; 17(6):671-9. PubMed ID: 6895501
[No Abstract] [Full Text] [Related]
5. Induction of petite mutants in yeast by non-intercalative DNA-binding antitumour agents.
Ferguson LR; Baguley BC
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1575-83. PubMed ID: 6357806
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1984 Aug; 27(8):1053-6. PubMed ID: 6747989
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T4 bacteriophage yield by 9-anilinoacridines; comparison with in vivo antitumour activity.
Robertson IG; Denny WA; Baguley BC
Eur J Cancer (1965); 1980 Sep; 16(9):1133-9. PubMed ID: 7227441
[No Abstract] [Full Text] [Related]
8. Potential antitumor agents. 37. Organophosphorus derivatives of 9-anilinoacridine.
Rewcastle GW; Baguley BC; Cain BF
J Med Chem; 1982 Oct; 25(10):1231-5. PubMed ID: 7143362
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic mutagenic action of acridine compounds on yeast Saccharomyces cerevisiae.
Iwamoto Y; Mifuchi I; Yielding LW
Mutat Res; 1985 Dec; 158(3):169-75. PubMed ID: 3908930
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of mutagenic, DNA binding and antileukaemic properties of 9-anilinoacridine derivatives and related compounds.
Ferguson LR; MacPhee DG; Baguley BC
Chem Biol Interact; 1983; 44(1-2):53-62. PubMed ID: 6342827
[No Abstract] [Full Text] [Related]
11. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
12. Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae.
Baguley BC; Turner PM; Ferguson LR
Eur J Cancer; 1990 Jan; 26(1):55-60. PubMed ID: 2138480
[TBL] [Abstract][Full Text] [Related]
13. 'Petite' mutagenesis in Saccharomyces cerevisiae by a series of 2,7-di-alkyl-substituted derivatives of proflavine with differing DNA-binding properties.
Ferguson LR; Denny WA; Feigon J
Mutat Res; 1988 Sep; 201(1):213-8. PubMed ID: 3047573
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor agents. 41. Analogues of amsacrine with electron-donor substituents in the anilino ring.
Atwell GJ; Rewcastle GW; Denny WA; Cain BF; Baguley BC
J Med Chem; 1984 Mar; 27(3):367-72. PubMed ID: 6546591
[TBL] [Abstract][Full Text] [Related]
15. Differential growth inhibition of cultured mammalian cells: comparison of clinical antitumour agents and amsacrine derivatives.
Wilson WR; Tapp SM; Baguley BC
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):383-9. PubMed ID: 6546720
[TBL] [Abstract][Full Text] [Related]
16. Petite induction in Saccharomyces cerevisiae by ethidium analogs: distinction between resting and growing cells.
Fukunaga M; Yielding LW; Firth WJ; Yielding KL
Mutat Res; 1980 Jun; 78(2):151-7. PubMed ID: 6993943
[TBL] [Abstract][Full Text] [Related]
17. Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1619-25. PubMed ID: 6688829
[TBL] [Abstract][Full Text] [Related]
18. Redox chemistry of the 9-anilinoacridine class of antitumor agents.
Jurlina JL; Lindsay A; Packer JE; Baguley BC; Denny WA
J Med Chem; 1987 Mar; 30(3):473-80. PubMed ID: 3820217
[TBL] [Abstract][Full Text] [Related]
19. Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity.
Denny WA; Atwell GJ; Baguley BC
J Med Chem; 1983 Nov; 26(11):1625-30. PubMed ID: 6688830
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis.
Gao H; Denny WA; Garg R; Hansch C
Chem Biol Interact; 1998 Nov; 116(3):157-80. PubMed ID: 9920460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
